San Francisco, California Mar 5, 2025 (Issuewire.com) - MDalgorithms Inc., a leader in AI-driven personalized dermatological care, today announced the publication of groundbreaking clinical trial results in the March 2025 issue of the Journal of Drugs in Dermatology. The study is the first third-party clinical trial evaluating its MDhair.co AI-personalized hair loss treatments for women demonstrates that MDalgorithms' proprietary platform significantly enhances hair growth, reduces shedding, and improves scalp healthoffering a cost-effective and accessible alternative to expensive dermatologist visits and generic over-the-counter treatments.
Key Clinical Findings: A Game-Changer for Hair Loss Treatment
In a 24-week, single-blind trial involving 38 women with self-reported hair thinning27 of whom completed the studythe AI-driven platform tailored treatment kits based on scalp imaging and a comprehensive dermatological questionnaire. The results showed:
Significant Hair Growth & Density Improvements Expert grading confirmed statistically significant increases in hair volume, thickness, and scalp coverage (P < 0.001).
37.3% Reduction in Hair Shedding at 12 Weeks Participants saw a 32.4% reduction in shedding by 24 weeks, marking a major improvement in hair retention.
Stronger Scalp Barrier Function Measurements of transepidermal water loss (TEWL) were reduced by 61.5% at 12 weeks and 69% at 24 weeks, reflecting a healthier, more resilient scalp.
Overwhelmingly Positive User Feedback
- 88.9% reported visible hair improvement
- 85.2% noted better scalp health
- 92.6% observed reduced hair brittleness
Advanced Imaging Confirms Efficacy Scanning electron microscopy (SEM) showed clear improvements in hair texture and structural integrity.
More On Iglobalupdate ::
- PayNGO - A Cryptocurrency to help finance NGOs that helps to raise funds in a PayNGO platform
- Todd Brubaker, DO, FAAP: A Respected Pediatric - Newborn Hospitalist Making a Difference in Children’s Healthcare
- Viva Naturals Introduces Vitamin D3 Supplements with Organic Coconut Oil
- Introducing John Matthews, MD: A Board-Certified, Fellowship-Trained Orthopedic Sports Medicine Surgeon
- Geelong's 'The Team Approach' Sets New Benchmarks in Corporate Mental Wellness
Transforming Hair Loss Care with AI-Powered Personalization
These results validate the power of our AI-driven platform to deliver personalized, multi-targeted treatments that outperform traditional one-size-fits-all approaches, said Oded Harth, CEO of MDalgorithms Inc. Our technology, leveraging advanced computer vision and deep learning, offers a scalable, affordable alternative to conventional dermatologist visits, providing superior outcomes for women struggling with hair loss.
Unlike generic solutions, MDalgorithms treatment kits are uniquely tailored to each individuals hair loss profile, combining:
- Dermatologist-formulated topical serums
- Advanced scalp-nourishing shampoos
- Targeted oral supplements
- Marine collagen peptides for enhanced hair strength
Importantly, the study reported no treatment-related adverse events, further reinforcing the safety and efficacy of MDalgorithms personalized approach.
A Mission to Democratize Dermatology
With hair loss affecting millions of women, our goal is to make high-quality, customized treatment accessible to all, added Dr. Yoram Harth, Chief Medical Officer of MDalgorithms. This study not only proves the clinical effectiveness of our AI-powered solution but also positions MDalgorithms as a transformative force in modern dermatology.
Learn More
For full study details and information on MDalgorithms AI-powered hair loss solutions, visit www.MDhair.co and www.MDalgorithms.com.
About MDalgorithms Inc.
MDalgorithms Inc. is pioneering AI-powered personalized dermatology, leveraging advanced machine learning and a proprietary database of over 47,000 scalp images to create customized, effective, and affordable treatments for hair and skin concerns. By combining cutting-edge technology with medical expertise, MDalgorithms is revolutionizing dermatological care for a global audience.
Source :MDalgorithms Inc.
This article was originally published by IssueWire. Read the original article here.